Quantum Genomics announced the appointment of Marc Karako and Dr. Jean Philippe Milon as CFO and COO respectively. Both positions will support Lionel Ségard, chairman and CEO, and Fabrice Balavoine, vice president Research & Development, strengthening the management team of the company. Karako has previously served as group CFO and EVP of Carlson Wagonlit Travel, he was also group chief financial and legal officer of Vallourec and vice president finance at Thomson.

Additionally he held various financial management positions at IBM Europe from 1985 to 1995. Dr. Milon served in various management positions at local and international level at Bayer where he was involved in primary care and cardiology, he joined the executive committee of Bayer to lead the global operations of mergers and acquisitions, licensing and business development. Additionally he managed the cardiovascular franchise of Sandoz.

In his new role at Quantum Genomics, Dr. Milon will be responsible for the business development strategy of whose objective is to conclude, during phase 2, a partnership agreement with a pharmaceutical company regarding QGC001, its first in class drug candidate for the treatment of hypertension. Call Send SMS Add to Skype You'll need Skype CreditFree via Skype.